Laura Civiero - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Laura Civiero

Showing results (31-40 of 40) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 40 results.

NPJ Parkinson'S Disease|July 19, 2022

LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson's diseaseMaria Kedariti, Emanuele Frattini, Pascale Baden, et al.

Frontiers in Molecular Neuroscience|January 10, 2018

PAK6 Phosphorylates 14-3-3γ to Regulate Steady State Phosphorylation of LRRK2Laura Civiero, Susanna Cogo, Anneleen Kiekens, et al.

Brain Research|January 12, 2022

The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylationSusanna Cogo, Franz Y Ho, Elena Tosoni, et al.

Frontiers in Molecular Neuroscience|January 3, 2024

PAK6-mediated phosphorylation of PPP2R2C regulates LRRK2-PP2A complex formationLucia Iannotta, Marco Emanuele, Giulia Favetta, et al.

Acta Neuropathologica|May 21, 2022

Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson's diseaseLudovica Iovino, Veronica Giusti, Francesca Pischedda, et al.

Journal of Neurochemistry|September 17, 2015

Leucine-rich repeat kinase 2 interacts with p21-activated kinase 6 to control neurite complexity in mammalian brainLaura Civiero, Maria Daniela Cirnaru, Alexandra Beilina, et al.

Frontiers in Molecular Neuroscience|March 16, 2018

The LRRK2 Variant E193K Prevents Mitochondrial Fission Upon MPP+ Treatment by Altering LRRK2 Binding to DRP1Maria Perez Carrion, Francesca Pischedda, Alice Biosa, et al.

Cell Death & Disease|October 17, 2024

PAK6 rescues pathogenic LRRK2-mediated ciliogenesis and centrosomal cohesion defects in a mutation-specific mannerLucia Iannotta, Rachel Fasiczka, Giulia Favetta, et al.

Proceedings of the National Academy of Sciences of the United States of America|February 11, 2014

Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson diseaseAlexandria Beilina, Iakov N Rudenko, Alice Kaganovich, et al.

Parkinsonism & Related Disorders|March 3, 2020

Co-occurring WARS2 and CHRNA6 mutations in a child with a severe form of infantile parkinsonismSimone Martinelli, Viviana Cordeddu, Serena Galosi, et al.

Pageof 4

Search research articles

Showing results (31-40 of 40) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 40 results.

NPJ Parkinson'S Disease|July 19, 2022

LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson's diseaseMaria Kedariti, Emanuele Frattini, Pascale Baden, et al.

Frontiers in Molecular Neuroscience|January 10, 2018

PAK6 Phosphorylates 14-3-3γ to Regulate Steady State Phosphorylation of LRRK2Laura Civiero, Susanna Cogo, Anneleen Kiekens, et al.

Brain Research|January 12, 2022

The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylationSusanna Cogo, Franz Y Ho, Elena Tosoni, et al.

Frontiers in Molecular Neuroscience|January 3, 2024

PAK6-mediated phosphorylation of PPP2R2C regulates LRRK2-PP2A complex formationLucia Iannotta, Marco Emanuele, Giulia Favetta, et al.

Acta Neuropathologica|May 21, 2022

Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson's diseaseLudovica Iovino, Veronica Giusti, Francesca Pischedda, et al.

Journal of Neurochemistry|September 17, 2015

Leucine-rich repeat kinase 2 interacts with p21-activated kinase 6 to control neurite complexity in mammalian brainLaura Civiero, Maria Daniela Cirnaru, Alexandra Beilina, et al.

Frontiers in Molecular Neuroscience|March 16, 2018

The LRRK2 Variant E193K Prevents Mitochondrial Fission Upon MPP+ Treatment by Altering LRRK2 Binding to DRP1Maria Perez Carrion, Francesca Pischedda, Alice Biosa, et al.

Cell Death & Disease|October 17, 2024

PAK6 rescues pathogenic LRRK2-mediated ciliogenesis and centrosomal cohesion defects in a mutation-specific mannerLucia Iannotta, Rachel Fasiczka, Giulia Favetta, et al.

Proceedings of the National Academy of Sciences of the United States of America|February 11, 2014

Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson diseaseAlexandria Beilina, Iakov N Rudenko, Alice Kaganovich, et al.

Parkinsonism & Related Disorders|March 3, 2020

Co-occurring WARS2 and CHRNA6 mutations in a child with a severe form of infantile parkinsonismSimone Martinelli, Viviana Cordeddu, Serena Galosi, et al.

Pageof 4